Concerning PNPLA3, there was a highly significant shift towards the reduction of CC homozygous and the increase of homozygous for the minor G allele (GG) when passing from healthy controls, through noncirrhotic NAFLD patients, to NASH cirrhotics. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.